Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Identifieur interne : 000F52 ( PubMed/Corpus ); précédent : 000F51; suivant : 000F53Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Auteurs : Claus F. Vogelmeier ; Gerard J. Criner ; Fernando J. Martinez ; Antonio Anzueto ; Peter J. Barnes ; Jean Bourbeau ; Bartolome R. Celli ; Rongchang Chen ; Marc Decramer ; Leonardo M. Fabbri ; Peter Frith ; David M G. Halpin ; M Victorina L Pez Varela ; Masaharu Nishimura ; Nicolas Roche ; Roberto Rodriguez-Roisin ; Don D. Sin ; Dave Singh ; Robert Stockley ; J Rgen Vestbo ; Jadwiga A. Wedzicha ; Alvar AgustíSource :
- American journal of respiratory and critical care medicine [ 1535-4970 ] ; 2017.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Bronchodilator Agents.
- diagnosis : Pulmonary Disease, Chronic Obstructive.
- prevention & control : Pulmonary Disease, Chronic Obstructive.
- therapy : Pulmonary Disease, Chronic Obstructive.
- Global Health, Humans, Internationality, Risk Factors, Spirometry.
Abstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
DOI: 10.1164/rccm.201701-0218PP
PubMed: 28128970
Links to Exploration step
pubmed:28128970Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.</title><author><name sortKey="Vogelmeier, Claus F" sort="Vogelmeier, Claus F" uniqKey="Vogelmeier C" first="Claus F" last="Vogelmeier">Claus F. Vogelmeier</name><affiliation><nlm:affiliation>1 University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Criner, Gerard J" sort="Criner, Gerard J" uniqKey="Criner G" first="Gerard J" last="Criner">Gerard J. Criner</name><affiliation><nlm:affiliation>2 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Martinez, Fernando J" sort="Martinez, Fernando J" uniqKey="Martinez F" first="Fernando J" last="Martinez">Fernando J. Martinez</name><affiliation><nlm:affiliation>3 New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Anzueto, Antonio" sort="Anzueto, Antonio" uniqKey="Anzueto A" first="Antonio" last="Anzueto">Antonio Anzueto</name><affiliation><nlm:affiliation>4 University of Texas Health Science Center, San Antonio, Texas.</nlm:affiliation></affiliation></author><author><name sortKey="Barnes, Peter J" sort="Barnes, Peter J" uniqKey="Barnes P" first="Peter J" last="Barnes">Peter J. Barnes</name><affiliation><nlm:affiliation>6 National Heart and Lung Institute, Imperial College, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Bourbeau, Jean" sort="Bourbeau, Jean" uniqKey="Bourbeau J" first="Jean" last="Bourbeau">Jean Bourbeau</name><affiliation><nlm:affiliation>7 McGill University Health Centre, McGill University, Montreal, Quebec, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Celli, Bartolome R" sort="Celli, Bartolome R" uniqKey="Celli B" first="Bartolome R" last="Celli">Bartolome R. Celli</name><affiliation><nlm:affiliation>8 Brigham and Women's Hospital, Boston, Massachusetts.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Rongchang" sort="Chen, Rongchang" uniqKey="Chen R" first="Rongchang" last="Chen">Rongchang Chen</name><affiliation><nlm:affiliation>9 State Key Lab for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Decramer, Marc" sort="Decramer, Marc" uniqKey="Decramer M" first="Marc" last="Decramer">Marc Decramer</name><affiliation><nlm:affiliation>10 University of Leuven, Leuven, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Fabbri, Leonardo M" sort="Fabbri, Leonardo M" uniqKey="Fabbri L" first="Leonardo M" last="Fabbri">Leonardo M. Fabbri</name><affiliation><nlm:affiliation>11 University of Modena and Reggio Emilia, Modena, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Frith, Peter" sort="Frith, Peter" uniqKey="Frith P" first="Peter" last="Frith">Peter Frith</name><affiliation><nlm:affiliation>12 Faculty of Medicine, Flinders University, Bedford Park, South Australia, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Halpin, David M G" sort="Halpin, David M G" uniqKey="Halpin D" first="David M G" last="Halpin">David M G. Halpin</name><affiliation><nlm:affiliation>13 Royal Devon and Exeter Hospital, Exeter, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="L Pez Varela, M Victorina" sort="L Pez Varela, M Victorina" uniqKey="L Pez Varela M" first="M Victorina" last="L Pez Varela">M Victorina L Pez Varela</name><affiliation><nlm:affiliation>14 Universidad de la República, Hospital Maciel, Montevideo, Uruguay.</nlm:affiliation></affiliation></author><author><name sortKey="Nishimura, Masaharu" sort="Nishimura, Masaharu" uniqKey="Nishimura M" first="Masaharu" last="Nishimura">Masaharu Nishimura</name><affiliation><nlm:affiliation>15 Hokkaido University School of Medicine, Sapporo, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Roche, Nicolas" sort="Roche, Nicolas" uniqKey="Roche N" first="Nicolas" last="Roche">Nicolas Roche</name><affiliation><nlm:affiliation>16 Hôpital Cochin (Assistance Publique-Hôpitaux de Paris), University Paris Descartes, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rodriguez Roisin, Roberto" sort="Rodriguez Roisin, Roberto" uniqKey="Rodriguez Roisin R" first="Roberto" last="Rodriguez-Roisin">Roberto Rodriguez-Roisin</name><affiliation><nlm:affiliation>17 Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Sin, Don D" sort="Sin, Don D" uniqKey="Sin D" first="Don D" last="Sin">Don D. Sin</name><affiliation><nlm:affiliation>18 St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Singh, Dave" sort="Singh, Dave" uniqKey="Singh D" first="Dave" last="Singh">Dave Singh</name><affiliation><nlm:affiliation>19 University of Manchester, Manchester, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Stockley, Robert" sort="Stockley, Robert" uniqKey="Stockley R" first="Robert" last="Stockley">Robert Stockley</name><affiliation><nlm:affiliation>20 University Hospital, Birmingham, United Kingdom; and.</nlm:affiliation></affiliation></author><author><name sortKey="Vestbo, J Rgen" sort="Vestbo, J Rgen" uniqKey="Vestbo J" first="J Rgen" last="Vestbo">J Rgen Vestbo</name><affiliation><nlm:affiliation>19 University of Manchester, Manchester, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Wedzicha, Jadwiga A" sort="Wedzicha, Jadwiga A" uniqKey="Wedzicha J" first="Jadwiga A" last="Wedzicha">Jadwiga A. Wedzicha</name><affiliation><nlm:affiliation>6 National Heart and Lung Institute, Imperial College, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Agusti, Alvar" sort="Agusti, Alvar" uniqKey="Agusti A" first="Alvar" last="Agustí">Alvar Agustí</name><affiliation><nlm:affiliation>21 Hospital Clínic, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Enfermedade Respiratorias, Barcelona, Spain.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28128970</idno><idno type="pmid">28128970</idno><idno type="doi">10.1164/rccm.201701-0218PP</idno><idno type="wicri:Area/PubMed/Corpus">000F52</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F52</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.</title><author><name sortKey="Vogelmeier, Claus F" sort="Vogelmeier, Claus F" uniqKey="Vogelmeier C" first="Claus F" last="Vogelmeier">Claus F. Vogelmeier</name><affiliation><nlm:affiliation>1 University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Criner, Gerard J" sort="Criner, Gerard J" uniqKey="Criner G" first="Gerard J" last="Criner">Gerard J. Criner</name><affiliation><nlm:affiliation>2 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.</nlm:affiliation></affiliation></author><author><name sortKey="Martinez, Fernando J" sort="Martinez, Fernando J" uniqKey="Martinez F" first="Fernando J" last="Martinez">Fernando J. Martinez</name><affiliation><nlm:affiliation>3 New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Anzueto, Antonio" sort="Anzueto, Antonio" uniqKey="Anzueto A" first="Antonio" last="Anzueto">Antonio Anzueto</name><affiliation><nlm:affiliation>4 University of Texas Health Science Center, San Antonio, Texas.</nlm:affiliation></affiliation></author><author><name sortKey="Barnes, Peter J" sort="Barnes, Peter J" uniqKey="Barnes P" first="Peter J" last="Barnes">Peter J. Barnes</name><affiliation><nlm:affiliation>6 National Heart and Lung Institute, Imperial College, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Bourbeau, Jean" sort="Bourbeau, Jean" uniqKey="Bourbeau J" first="Jean" last="Bourbeau">Jean Bourbeau</name><affiliation><nlm:affiliation>7 McGill University Health Centre, McGill University, Montreal, Quebec, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Celli, Bartolome R" sort="Celli, Bartolome R" uniqKey="Celli B" first="Bartolome R" last="Celli">Bartolome R. Celli</name><affiliation><nlm:affiliation>8 Brigham and Women's Hospital, Boston, Massachusetts.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Rongchang" sort="Chen, Rongchang" uniqKey="Chen R" first="Rongchang" last="Chen">Rongchang Chen</name><affiliation><nlm:affiliation>9 State Key Lab for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Decramer, Marc" sort="Decramer, Marc" uniqKey="Decramer M" first="Marc" last="Decramer">Marc Decramer</name><affiliation><nlm:affiliation>10 University of Leuven, Leuven, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Fabbri, Leonardo M" sort="Fabbri, Leonardo M" uniqKey="Fabbri L" first="Leonardo M" last="Fabbri">Leonardo M. Fabbri</name><affiliation><nlm:affiliation>11 University of Modena and Reggio Emilia, Modena, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Frith, Peter" sort="Frith, Peter" uniqKey="Frith P" first="Peter" last="Frith">Peter Frith</name><affiliation><nlm:affiliation>12 Faculty of Medicine, Flinders University, Bedford Park, South Australia, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Halpin, David M G" sort="Halpin, David M G" uniqKey="Halpin D" first="David M G" last="Halpin">David M G. Halpin</name><affiliation><nlm:affiliation>13 Royal Devon and Exeter Hospital, Exeter, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="L Pez Varela, M Victorina" sort="L Pez Varela, M Victorina" uniqKey="L Pez Varela M" first="M Victorina" last="L Pez Varela">M Victorina L Pez Varela</name><affiliation><nlm:affiliation>14 Universidad de la República, Hospital Maciel, Montevideo, Uruguay.</nlm:affiliation></affiliation></author><author><name sortKey="Nishimura, Masaharu" sort="Nishimura, Masaharu" uniqKey="Nishimura M" first="Masaharu" last="Nishimura">Masaharu Nishimura</name><affiliation><nlm:affiliation>15 Hokkaido University School of Medicine, Sapporo, Japan.</nlm:affiliation></affiliation></author><author><name sortKey="Roche, Nicolas" sort="Roche, Nicolas" uniqKey="Roche N" first="Nicolas" last="Roche">Nicolas Roche</name><affiliation><nlm:affiliation>16 Hôpital Cochin (Assistance Publique-Hôpitaux de Paris), University Paris Descartes, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rodriguez Roisin, Roberto" sort="Rodriguez Roisin, Roberto" uniqKey="Rodriguez Roisin R" first="Roberto" last="Rodriguez-Roisin">Roberto Rodriguez-Roisin</name><affiliation><nlm:affiliation>17 Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Sin, Don D" sort="Sin, Don D" uniqKey="Sin D" first="Don D" last="Sin">Don D. Sin</name><affiliation><nlm:affiliation>18 St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Singh, Dave" sort="Singh, Dave" uniqKey="Singh D" first="Dave" last="Singh">Dave Singh</name><affiliation><nlm:affiliation>19 University of Manchester, Manchester, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Stockley, Robert" sort="Stockley, Robert" uniqKey="Stockley R" first="Robert" last="Stockley">Robert Stockley</name><affiliation><nlm:affiliation>20 University Hospital, Birmingham, United Kingdom; and.</nlm:affiliation></affiliation></author><author><name sortKey="Vestbo, J Rgen" sort="Vestbo, J Rgen" uniqKey="Vestbo J" first="J Rgen" last="Vestbo">J Rgen Vestbo</name><affiliation><nlm:affiliation>19 University of Manchester, Manchester, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Wedzicha, Jadwiga A" sort="Wedzicha, Jadwiga A" uniqKey="Wedzicha J" first="Jadwiga A" last="Wedzicha">Jadwiga A. Wedzicha</name><affiliation><nlm:affiliation>6 National Heart and Lung Institute, Imperial College, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Agusti, Alvar" sort="Agusti, Alvar" uniqKey="Agusti A" first="Alvar" last="Agustí">Alvar Agustí</name><affiliation><nlm:affiliation>21 Hospital Clínic, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Enfermedade Respiratorias, Barcelona, Spain.</nlm:affiliation></affiliation></author></analytic><series><title level="j">American journal of respiratory and critical care medicine</title><idno type="eISSN">1535-4970</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bronchodilator Agents (therapeutic use)</term><term>Global Health</term><term>Humans</term><term>Internationality</term><term>Pulmonary Disease, Chronic Obstructive (diagnosis)</term><term>Pulmonary Disease, Chronic Obstructive (prevention & control)</term><term>Pulmonary Disease, Chronic Obstructive (therapy)</term><term>Risk Factors</term><term>Spirometry</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bronchodilator Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Global Health</term><term>Humans</term><term>Internationality</term><term>Risk Factors</term><term>Spirometry</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28128970</PMID><DateCreated><Year>2017</Year><Month>01</Month><Day>27</Day></DateCreated><DateCompleted><Year>2017</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>195</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am. J. Respir. Crit. Care Med.</ISOAbbreviation></Journal><ArticleTitle>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.</ArticleTitle><Pagination><MedlinePgn>557-582</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201701-0218PP</ELocationID><Abstract><AbstractText>This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vogelmeier</LastName><ForeName>Claus F</ForeName><Initials>CF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-9798-2527</Identifier><AffiliationInfo><Affiliation>1 University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criner</LastName><ForeName>Gerard J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>2 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Fernando J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>3 New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anzueto</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>4 University of Texas Health Science Center, San Antonio, Texas.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 South Texas Veterans Health Care System, San Antonio, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>6 National Heart and Lung Institute, Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourbeau</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>7 McGill University Health Centre, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celli</LastName><ForeName>Bartolome R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>8 Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rongchang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>9 State Key Lab for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decramer</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>10 University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Leonardo M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>11 University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frith</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>12 Faculty of Medicine, Flinders University, Bedford Park, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halpin</LastName><ForeName>David M G</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>13 Royal Devon and Exeter Hospital, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López Varela</LastName><ForeName>M Victorina</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>14 Universidad de la República, Hospital Maciel, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Masaharu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>15 Hokkaido University School of Medicine, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roche</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>16 Hôpital Cochin (Assistance Publique-Hôpitaux de Paris), University Paris Descartes, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Roisin</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>17 Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Don D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>18 St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Dave</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>19 University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stockley</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>20 University Hospital, Birmingham, United Kingdom; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vestbo</LastName><ForeName>Jørgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>19 University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wedzicha</LastName><ForeName>Jadwiga A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>6 National Heart and Lung Institute, Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agustí</LastName><ForeName>Alvar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>21 Hospital Clínic, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Enfermedade Respiratorias, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G0800570</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1001365</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1001372</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038622" MajorTopicYN="N">Internationality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COPD diagnosis</Keyword><Keyword MajorTopicYN="N">COPD management</Keyword><Keyword MajorTopicYN="N">COPD prevention</Keyword><Keyword MajorTopicYN="N">chronic obstructive pulmonary disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28128970</ArticleId><ArticleId IdType="doi">10.1164/rccm.201701-0218PP</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28128970
|texte= Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28128970" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |